Volume 4 Supplement 1
PD44 - In vitro fertilisation is positively associated with prevalence of asthma in childhood
© Guibas et al; licensee BioMed Central Ltd. 2014
Published: 28 February 2014
Research on potential perinatal risk factors for asthma, has recently attracted considerable attention. Asthma could be associated with In vitro fertilization (IVF) via epigenetic modification of DNA by IVF drugs/hormones or via a genetic link of asthma with parental subfertility. Nevertheless, evidence of an asthma/IVF correlation is scarce and inconclusive. We therefore opted to explore a potential link, in a cross-sectional population-based study in preadolescent children.
Wheeze in the last 12 months (current), wheeze ever, physician-diagnosed asthma and method of conception were recorded from questionnaires filled in by the parents of 2016 Greek children aged 9-13. Perinatal data was collected from their medical records and the questionnaires; anthropometric measurements were conducted. Logistic regression models were build in the Statistical Package for Social Sciences (SPSS version 20.0), with the wheeze/asthma variables as main outcomes. A two-tailed p value less that 0.05, was considered statistically significant.
IVF correlated with physician-diagnosed asthma (OR=2.69, 95%CI=1.5-4.79, p=0.001) and ever wheeze (OR=2.01, 95%CI=1.07-3.78, p=0.03) but not with current wheeze (p>0.05) in univariate unadjusted regression models. The link of IVF with asthma remained significant (OR=2.04, 95%CI=1-4.15, p=0.05) after adjustment for a wide array of potential confounding factors (maternal prenatal smoking, gestational age, single or multiple gestation, method of delivery, birth weight, gender, parity, breastfeeding, parental educational level, passive smoking at home, current BMI, family status, mother occupation, people involved in daily childcare and municipality/county/urbanity wherein the subjects resided). However the link with ever wheeze was lost (p>0.05).
Conception via in vitro fertilization may predispose children to future asthma development.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.